Results 171 to 180 of about 8,840 (216)
Some of the next articles are maybe not open access.

Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations (2527)

Neurology, 2021
Laura Cacciaguerra   +7 more
openaire   +1 more source

Comparison of vision-related quality of life in NMOSD and MOGAD

open access: yesMultiple Sclerosis and Related Disorders
Background: Aquaporin-4 antibody positive neuromyelitis spectrum disorder (AQP4+ NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) are both associated with vision loss due to optic neuritis (ON), although evidence suggests more ...
Dalia Rotstein, Liesly Lee
exaly   +1 more source

Tocilizumab, MS, and NMOSD

Multiple Sclerosis Journal, 2016
Ingo, Kleiter   +4 more
openaire   +2 more sources

NMOSD: Innate Immunology Revisited

Clinical and Experimental Neuroimmunology
ABSTRACT Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune/inflammatory disease of the central nervous system (CNS) that causes severe neurological deficits, including optic neuritis and longitudinally extensive myelitis.
Fumihiro Yanagimura   +3 more
openaire   +1 more source

Inebilizumab gegen NMOSD

InFo Neurologie + Psychiatrie, 2021
openaire   +1 more source

Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors

Multiple Sclerosis Journal, 2023
Berenice Silva   +2 more
exaly  

A national case–control study investigating demographic and environmental factors associated with NMOSD

Multiple Sclerosis Journal, 2023
Ruth Ann Marrie   +2 more
exaly  

Seeking transpaRINcy for rituximab dosing in NMOSD

The Lancet Neurology, 2020
Antonia J, Clarke   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy